Results generated to date serve as basis for new IP filings and conference presentations, and have led to an expansion of the collaboration beyond CAR T cells SAN FRANCISCO — Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, today announced it has achieved key milestones in its R&D collaboration with Labcorp, […]
The recently launched HaLCon Analyzer from RedShiftBio and the Flownamics Director are perfectly suited to jointly deliver HPLC-quality protein titer for bioprocessing with even greater efficiency and throughput. BOXBOROUGH, Mass. — RedShift BioAnalytics (RedShiftBio®) today announced that it has signed a global distribution agreement with Flownamics for the Director™ Sample Distribution System. The Director™ from Flownamics […]
Synthego to develop multiplexed and complex genetic engineering strategies, increasing the safety and speed at which bit.bio can engineer human cells for cell therapies. bit.bio aims to leverage technology to increase efficiency of human cell engineering and accelerate the development of highly scalable cell therapies that are capable of treating millions of patients. Redwood City, […]
Rentschler Biopharma, Cell and Gene Therapy Catapult and Refeyn announce collaboration The collaborators will use automated and digital technologies to improve the process of manufacturing adeno-associated viruses (AAV) Stevenage and London, UK, and Laupheim, Germany– Rentschler Biopharma, a leading global contract development and manufacturing organisation (CDMO) for biopharmaceuticals, including advanced therapy medicinal products (ATMPs), announces a […]
Results generated to date serve as basis for new IP filings and conference presentations, and have led to an expansion of the collaboration beyond CAR T cells SAN FRANCISCO — Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, today announced it has achieved key milestones in its R&D collaboration […]
Gustave Roussy uses SOPHiA DDM™ Platform to empower confident, data-driven medicine in the fight against cancer BOSTON and ROLLE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced the expansion of its relationship with Gustave Roussy, the leading cancer center in Europe. With the expanded relationship SOPHiA GENETICS will now further […]
SEOUL, South Korea — MGI, a company committed to building core tools and technology to lead life science and NGeneBio, a company specializing in next-generation sequencing-based diagnostic have signed a memorandum of understanding (MOU) to expand the commercial access of NGeneBio’s cancer testing products globally. This strategic partnership will enable the integration of NGeneBio’s advanced diagnostic […]
New collaboration aims to broaden access to nanopore sequencing technology to accelerate patient diagnosis and genomic research Oxford Nanopore Technologies plc (Oxford Nanopore), the company delivering a new generation of nanopore-based molecular sensing technology, and IQVIA, a leading global provider of advanced analytics, technology solutions and clinical research services in healthcare and life sciences, has […]
SAN DIEGO — Scale Biosciences, a pioneer in single-cell sequencing technology, today announced a new collaboration with Basepair to provide point and click bioinformatic analysis of single-cell data produced with its patented and disruptive combinatorial indexing technology. As a result of this collaboration, scientists will be able to access Scale Biosciences’ optimized bioinformatics pipeline through […]
Sampled is now an Olink Service Provider Piscataway, NJ – Sampled1,The Global Integrated Analytical Biorepository, today announced that it has been named a Service Provider for Olink® Proteomics, a leader in Proteomics technology. As a service provider of Olink® Explore technology, Sampled now offers high throughput proteomics services for precise protein biomarker discovery. The Olink Explore […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
